PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
07-May-2025 Modern Dental Group Celebrates the Successful Conclusion of the  “Transformative Power of Digital Dentistry” Symposium 2025 Modern Dental Group Limited
06-May-2025 AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network becomes a partner of Mayo Clinic Care Network AEVIS VICTORIA SA
06-May-2025 Conference call on the results for the 2nd quarter 2024/2025 (ending 31 March 2025) on 15 May 2025 Douglas AG
06-May-2025 aap makes a stable start to financial year 2025 - growth in the region with the highest sales EMEA region aap Implantate AG
06-May-2025 Xlife Sciences AG Announces Strategic Collaboration between Portfolio Company Firstgene Life Sciences and Hovione in the Field of Gene Therapy Xlife Sciences AG
06-May-2025 SCHOTT Pharma and Serum Institute of India welcome new partner to Joint Venture in India; TPG makes strategic investment in SCHOTT Poonawalla SCHOTT Pharma AG & Co. KGaA
06-May-2025 Evotec SE reports Q1 2025 results: Paving the way for 2025 growth in soft market environment Evotec SE
05-May-2025 Xlife Sciences AG confirms sustainable value development and strategic scaling of the portfolio in the 2024 Valuation Report Xlife Sciences AG
03-May-2025 Vitruvia Medical AG: Year End results as of December 31,2024 Vitruvia Medical AG
02-May-2025 MEDICLIN increases group operating result in the first quarter of 2025 MEDICLIN AG
02-May-2025 Immunic to Participate in Scientific and Industry Conferences in May Immunic AG
01-May-2025 FDA Grants OKYO Pharma Fast Track Designation to Urcosimod for Neuropathic Corneal Pain OKYO Pharma Limited
01-May-2025 Clinigen announces key executive appointments to drive the next phase of growth and deliver increased investor value Clinigen
01-May-2025 Leqembi® ▼ (lecanemab) proposed Marketing Authorisation Variation for monthly intravenous maintenance dosing for the treatment of early Alzheimer’s disease (AD) in the UK is validated for evaluation by the MHRA Eisai
01-May-2025 Preliminary unaudited results for the year ended 31 December 2024 Commercial progress and order book growth Cambridge Cognition Holdings plc
30-Apr-2025 BRAIN Biotech AG reports preliminary Q2 figures and forecasts a more conservative development for the second half of the fiscal year 2024/25 BRAIN Biotech AG
30-Apr-2025 FamiCord AG continues growth course in 2024 after strong year-end business and stabilizes business development in home market Germany FamiCord AG
30-Apr-2025 Immunic Announces Vidofludimus Calcium Reduced Risk of Disability Worsening by 30% in Primary Progressive Multiple Sclerosis Patients from Phase 2 CALLIPER Trial Immunic AG
30-Apr-2025 Isomerase Enhances Process Innovation Capabilities for Protein Discovery and Production Isomerase
30-Apr-2025 Asklepios Group: Publication of Asklepios CSRD Report 2024 Asklepios Kliniken